NEW YORK, Sept. 08, 2016 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Envision Healthcare Holdings, Inc. (“Envision Healthcare” or the “Company”) (NYSE:EVHC) in the United States District Court for the District of Colorado on behalf of current stock holders of Envision Healthcare, seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”).
This action stems from a proposed transaction announced on June 15, 2016, pursuant to which Envision Healthcare will be acquired by AmSurg Corp. (“Parent”) through Parent’s wholly-owned subsidiary, New Amethyst Corp. (“Merger Sub,” and together with Parent, “AmSurg”). On June 15, 2016, the Board caused Envision to enter into an agreement and plan of merger (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, AmSurg will acquire all of the outstanding shares of Envision common stock for 0.334 AmSurg shares per Envision share, in a transaction valued at approximately $4.73 billion. The Complaint alleges that the Form S-4 Registration Statement omits material information with respect to the proposed transaction, which renders the Form S-4 Registration Statement false and misleading.
If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



